ArticleEuropean journal of clinical nutrition2026
Identification of PTPRR gene associated with cirrhosis and sarcopenia based on bioinformatics and machine learning.
Article in European journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirrhosis and sarcopenia frequently coexist and are associated with poor clinical outcomes; however, their shared genetic basis remains incompletely understood.
methodsWe applied conditional and conjunctional false discovery rate (cFDR/ccFDR) analyses to genome-wide association study (GWAS) summary statistics for cirrhosis and sarcopenia-related traits, including appendicular lean mass (ALM) and usual walking pace (UWP). In parallel, weighted gene co-expression network analysis (WGCNA) and three machine learning algorithms (LASSO, random forest, and support vector machine-recursive feature elimination) were applied to liver and skeletal muscle transcriptomes. External validation was performed using independent transcriptomic cohorts. Two-sample Mendelian randomization (MR) was conducted to explore causal directions.
resultsGWAS-based pleiotropic analysis identified seven shared genetic loci for both conditions cirrhosis and sarcopenia. Transcriptomic and machine learning analyses prioritized eight shared candidate genes across liver and skeletal muscle tissues, among which PTPRR emerged as a convergent candidate identified by multiple analytical layers. Functional enrichment revealed pleiotropic loci were primarily associated with lipid metabolism and inflammatory pathways, whereas machine learning-derived genes were enriched in intracellular signaling and transcriptional regulation. MR analyses further suggested that genetically predicted higher ALM and faster UWP were associated with a lower risk of cirrhosis (inverse-variance weighted [IVW] P = 0.0127 and 0.0211, respectively).
conclusionsBy jointly reporting pleiotropic genetic loci and shared candidate genes, this study provides a multi-layered view of the genetic architecture underlying cirrhosis-sarcopenia comorbidity and supports the robustness of the identified gene signature across independent transcriptomic datasets, highlighting candidate molecular targets for future mechanistic investigation.
Indexed as
Identifiers
42115738What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.